Research ArticleAccepted Article
Open Access
Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis
Nicki J.F. Verweij, Jerney de Jongh, Marieke M. ter Wee, Gerben J.C. Zwezerijnen, Maqsood Yaqub, Alexandre E. Voskuyl, Adriaan A. Lammertsma, Dirkjan van Schaardenburg, Maarten Boers, Willem F. Lems and Conny J. van der Laken
The Journal of Rheumatology April 2022, jrheum.210928; DOI: https://doi.org/10.3899/jrheum.210928
Nicki J.F. Verweij
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Jerney de Jongh
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Marieke M. ter Wee
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Gerben J.C. Zwezerijnen
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Maqsood Yaqub
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Alexandre E. Voskuyl
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Adriaan A. Lammertsma
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Dirkjan van Schaardenburg
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Maarten Boers
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Willem F. Lems
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
Conny J. van der Laken
Funding: This work was supported by Pfizer, Abbvie, ReumaNederland [14-1-302] and ZonMw [436001001]. Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade. Amsterdam. Conflict of interest: The authors declare no competing interests. Corresponding author: J. van der Laken, MD, PhD Department of Rheumatology, Amsterdam UMC – location VUmc, P.O. Box 7057, 1007 MB Amsterdam. E-mail: j.vanderlaken@amsterdamumc.nl
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis
Nicki J.F. Verweij, Jerney de Jongh, Marieke M. ter Wee, Gerben J.C. Zwezerijnen, Maqsood Yaqub, Alexandre E. Voskuyl, Adriaan A. Lammertsma, Dirkjan van Schaardenburg, Maarten Boers, Willem F. Lems, Conny J. van der Laken
The Journal of Rheumatology Apr 2022, jrheum.210928; DOI: 10.3899/jrheum.210928
Accepted manuscript
Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis
Nicki J.F. Verweij, Jerney de Jongh, Marieke M. ter Wee, Gerben J.C. Zwezerijnen, Maqsood Yaqub, Alexandre E. Voskuyl, Adriaan A. Lammertsma, Dirkjan van Schaardenburg, Maarten Boers, Willem F. Lems, Conny J. van der Laken
The Journal of Rheumatology Apr 2022, jrheum.210928; DOI: 10.3899/jrheum.210928